Another CAD risk locus from this study led to the prioritisation of MYO9B (unconventional myosin-IXb) as a candidate gene, a myosin protein with a Rho-GTPase-activating function that has a role in cell migration [11,40]. The gene discussed is MYO9B; the disease is coronary artery disorder.